cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer
- PMID: 751711
Item in Clipboard
cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer
Cancer Treat Rep.
1978 Dec.
Abstract
Treatment with a combination of adriamycin (ADM) and cis-dichlorodiammineplatinum(II) (DDP) has been evaluated in 24 patients with advanced ovarian cancer. Twenty patients had received prior chemotherapy and/or radiation therapy. Objective remissions were seen in ten patients. The usual toxic manifestations of ADM and DDP were observed. It is concluded that the combination is effective therapy for ovarian cancer. Further investigation of this combination versus single agents is warranted.
Similar articles
-
Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1745-53. Cancer Treat Rep. 1979. PMID: 393378 Clinical Trial. No abstract available.
-
Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1545-8. Cancer Treat Rep. 1979. PMID: 387225 Clinical Trial.
-
[Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)].Gan To Kagaku Ryoho. 1983 Apr;10(4 Pt 1):938-43. Gan To Kagaku Ryoho. 1983. PMID: 6683483 Japanese.
-
cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1539-44. Cancer Treat Rep. 1979. PMID: 387224 Review.
-
Medical therapy of advanced malignant epithelial tumours of the ovary.Forum (Genova). 2000 Oct-Dec;10(4):323-32. Forum (Genova). 2000. PMID: 11535983 Review.
Cited by
-
Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil.Cancer Chemother Pharmacol. 1985;15(2):179-80. doi: 10.1007/BF00257534. Cancer Chemother Pharmacol. 1985. PMID: 3839443